The impact of a restricted pregabalin prescription policy on drug utilization: An observational multicenter study

BACKGROUND: The Saudi Food and Drug Authority (SFDA) classified pregabalin as a controlled substance in 2018; however, whether this policy change has affected pregabalin use is unclear. This study examined the trends in pregabalin prescriptions before and after the SFDA restriction. In addition, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-jedai, Ahmed, Alkofide, Hadeel, Almohimeed, Lujaine, Alsalim, Lama, Alruwaili, Alya, Alissa, Dema A., Almudaiheem, Hajer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665920/
https://www.ncbi.nlm.nih.gov/pubmed/38028223
http://dx.doi.org/10.1016/j.jsps.2023.101851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665920/
https://www.ncbi.nlm.nih.gov/pubmed/38028223
http://dx.doi.org/10.1016/j.jsps.2023.101851

Ejemplares similares